There is a policy comment due out in Science today in which Genelex’s website is prejudicially quoted out of context.
The quote in the article is:
“Some Web sites make explicit claims about the utility of CYP450 testing for particular drugs, such as the claim by Genelex that pharmacogenetic testing is “required to effectively prescribe Paxil” (10).
The [...]
Filed under: Cytochrome P450, Drug Interactions, Personalized Medicine, Pharmacogenetics | Tagged: consumer driven healthcare, consumer right, CYP, DNA, P4 medicine, P450, Personalized Medicine, Pharmacogenetics, Science, testing | 3 Comments »
